BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Creatinine PAP SL, SEPPIM

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 06688/12

Corrective action of SEPPIM for Creatinine PAP SL due to a paraprotein interference. Customers were informed accordingly.

According to the information of the manufacturer German customers are not affected.

Corrective action for Creatinine PAP SL, SEPPIM , Download_VeroeffentlichtAm_EN PDF, 3MB, File does not meet accessibility standards